Campylobacter pyloridis--a new factor in peptic ulcer disease?
about
Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitisCampylobacter associated gastritis in patients with non-ulcer dyspepsia.Retrospective study of Campylobacter-like organisms in patients undergoing partial gastrectomyPeptic ulcer disease. Pathophysiology and current medical management.Helicobacter pylori and gastritis in patients with peptic ulcer and non-ulcer dyspepsia: ethnic differences in Singapore.Gastroduodenal mucosa in uraemia: endoscopic and histological correlation and prevalence of helicobacter-like organisms.Campylobacter associated gastritis in patients with non-ulcer dyspepsia: a double blind placebo controlled trial with colloidal bismuth subcitratePatterns of colonisation of Campylobacter pylori in the oesophagus, stomach and duodenumTwo-dimensional gel electrophoresis and immunoblotting of Campylobacter pylori proteins.In vitro activities of new oral beta-lactams and macrolides against Campylobacter pylori.Campylobacter pylori gastritis.In vitro susceptibility of Helicobacter pylori to several antimicrobial combinations.Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa.The genus Campylobacter: a decade of progress.Do non-steroidal anti-inflammatory drugs or smoking predispose to Helicobacter pylori infection?Campylobacter pyloridis: a new organism to explain an old problem?Diagnosis of Helicobacter pylori infection by using pyloriset EIA-G and EIA-A for detection of serum immunoglobulin G (IgG) and IgA antibodies.Case report of an unclassified microaerophilic bacterium associated with gastroenteritis.Evaluation of a commercial ELISA for serodiagnosis of Helicobacter pylori infection.Characterization of an immunoreactive species-specific 19-kilodalton outer membrane protein from Helicobacter pylori by using a monoclonal antibodyInfluence of ulcer healing agents on ulcer relapse after discontinuation of acute treatment: a pooled estimate of controlled clinical trials.Treatment failure of norfloxacin against Campylobacter pylori and chronic gastritis in patients with nonulcerative dyspepsiaConservation and diversity of Campylobacter pyloridis major antigens.Optimization of a medium for the rapid urease test for detection of Campylobacter pylori in gastric antral biopsies.Pepsinogens in health and disease.Campylobacter-like organisms and Candida in peptic ulcers and similar lesions of the upper gastrointestinal tract: a study of 247 cases.Helicobacter pylori survival in gastric mucosa by generation of a pH gradient.Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis.The characterization and pathological significance of gastric Campylobacter-like organisms in the ferret: a model for chronic gastritis?Comparative sensitivities to antimicrobial agents of Campylobacter pylori and the gastric campylobacter like organism from the ferret.Campylobacter colonisation, duodenal ulceration, and changes in gastric mucosa.Campylobacter pyloridis: what role in gastritis and peptic ulcer.Tripotassium dicitrato bismuthate on unhealed duodenal ulcers.Erosive prepyloric changes in patients with end-stage renal failure undergoing maintenance dialysis treatment.Age-dependent increase of Campylobacter pylori antibodies in blood donors.
P2860
Q33838114-E6F6DA9F-8B6F-45EF-B5ED-074F6D3283B0Q33838583-E291B953-D2A2-4E37-A85F-A6EE0CAE00CAQ33839701-5D0C293B-84D8-442E-B155-FA0416A077BAQ34195612-36DB767B-0B63-4A26-921B-277A4E33A865Q34392680-D9246F55-9EAC-4FAF-AAC6-9836D1C92A4DQ34393165-0D6D1085-F061-4F4C-B4C7-30DF956C5704Q34532392-0C9CE83D-97C6-415F-8632-1961FCCAF2E8Q34532820-6827DD7F-F197-4555-ADE0-62A745ABE1F6Q35097298-3F66482C-3E7E-41AC-BF21-1A3E718EF582Q35352378-4F7CD3BF-A9C2-4CE9-B9F6-F9052C4A7D4EQ35604591-D0A287AA-0BD6-4ABB-AE34-A2FA8B66CA94Q35815437-CC956D0C-D6CD-4D16-A098-8780EF2B22F9Q36230980-09C75D51-0950-4AC9-96E9-DF39584620B4Q36429451-5013E0F6-F68A-4F59-961A-F164497F30B5Q36718215-FDCBFA92-37EF-4FEB-A403-83EE0D647D0AQ36721493-53649447-C2C6-4EBC-A122-5CAC17E2A2F8Q37127994-4DA234D1-AECF-4FF5-A1EE-FA5B13DD95E1Q37142773-A4FA66AF-CB82-4337-963D-057BE75632D1Q37143449-4DE4861E-122A-485E-A093-4ED91D5FF8C6Q37240981-F15D7848-3955-4D74-83DB-B17053A1A852Q39466573-B7ABAADB-5DA9-4A2D-9642-396D5332C309Q39814993-AF332121-212D-440C-8F9F-5306BF3A6F39Q40163229-ADEC5829-E2C2-472A-87DB-10C87B001AD9Q40200697-A4B4790D-7403-46F2-8F36-865F4BB157ACQ40789961-FDA57EFC-13F6-4C70-8519-EE963366F4C3Q41375613-0EAFF3E4-7BBE-48B1-BD42-67368C549369Q41830544-263EC7BA-1D3E-4380-9C27-3E023AD3C898Q41878177-F8A2EFD4-B084-46AA-90BA-CD404FA128B0Q42151041-8C448DCA-4214-498B-B28D-41D178D39797Q42841229-EDC535BA-07C3-46C1-9070-1795ADDB4AB9Q42842411-C42BE56C-C3F5-4E7B-A53A-05ABD72D7569Q43175193-887439CA-E0F0-4BE3-9608-0CF216B7AF5BQ43198152-0A059892-5669-48D8-92A2-2046F6AF8043Q44242997-16D4D34D-632A-4DDA-A52B-EFE112516B5AQ44928567-8E2905CA-817A-4350-821D-1ECE066DC2B8
P2860
Campylobacter pyloridis--a new factor in peptic ulcer disease?
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Campylobacter pyloridis--a new factor in peptic ulcer disease?
@en
type
label
Campylobacter pyloridis--a new factor in peptic ulcer disease?
@en
prefLabel
Campylobacter pyloridis--a new factor in peptic ulcer disease?
@en
P2093
P2860
P356
P1433
P1476
Campylobacter pyloridis--a new factor in peptic ulcer disease?
@en
P2093
P2860
P304
P356
10.1136/GUT.27.6.635
P407
P577
1986-06-01T00:00:00Z